| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a427016c5eb9677aa82387672dcd3ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7729c1590ce7cfac83861541feb6e1d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf6c3f2d70c5f27e6b4268ac4a48d350 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate |
1991-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe28aa836b6ee46f618286988be0eee0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdf4febd336e929ea9eeab77e2944776
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_124590384fe17ebaff3f18b743072cac |
| publicationDate |
1991-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2041884-A1 |
| titleOfInvention |
Process for the selective modulation of the expression and function of a determinant on the cell surface by means of appropriate chemical agents |
| abstract |
ABSTRACT OF THE DISCLOSURE Use of N-dichloroacetyl lysoganyliosides, e.g. N-dichloroacetyl lyso GM1, in the manufacture or preparation of a pharmaceutical formulation for selectively modulating the CD4 determinant present on the surface of human cells. This modulation can be used therapeutically to treat neuroimmunopathological conditions or neuroimmunopathology associated with infection by viruses e.g. the HIV-I virus. |
| priorityDate |
1990-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |